A
40
-3
WMB
47
-21
SO
48
-29
XRAY
31
-13
EQR
44
5
PSA
46
-18
KIM
54
3
UNH
33
-23
AAL
51
-6
XRX
41
-18
DTE
36
2
T
29
-27
GOOG
67
-2
MCHP
47
2
VRSN
43
-20
CVS
33
-2
TEL
58
-24
GILD
50
3
PNW
59
-19
TSN
46
-16
A
40
-3
WMB
47
-21
SO
48
-29
XRAY
31
-13
EQR
44
5
PSA
46
-18
KIM
54
3
UNH
33
-23
AAL
51
-6
XRX
41
-18
DTE
36
2
T
29
-27
GOOG
67
-2
MCHP
47
2
VRSN
43
-20
CVS
33
-2
TEL
58
-24
GILD
50
3
PNW
59
-19
TSN
46
-16
Financhill
Back

Schwab Emerging Markets Equity ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
34

SCHE
Schwab Emerging Markets Equity ETF

Last Price:
$32.15
Seasonality Move:
1.32%
Sell
50

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$111.57
Seasonality Move:
-13.08%
Sell
34
Schwab Emerging Markets Equity ETF (SCHE) is a Sell

Is Schwab Emerging Markets Equity ETF a Buy, Sell or Hold?

  • The current Schwab Emerging Markets Equity ETF [SCHE] share price is $31.76. The Score for SCHE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • SCHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SCHE Stock Price Chart

What is Schwab Emerging Markets Equity ETF's stock price today?

  • The Schwab Emerging Markets Equity ETF share price today is $31.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCHE is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

SCHE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.53 Buy
Relative Strength Index (14 RSI): 26.94 Sell
Chaikin Money Flow: -3754489 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.58 - 33.74) Sell
Bollinger Bands (100): (31.64 - 33.82) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.92 Buy
Relative Strength Index (14 RSI): 57.01 Buy
Chaikin Money Flow: -264527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.99 - 110.55) Buy
Bollinger Bands (100): (94.91 - 108.39) Buy

SCHE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.66 Sell
20-day SMA: 33.03 Sell
50-day SMA: 33.44 Sell
200-day SMA: 30.69 Buy
8-day EMA: 7.06 Buy
20-day EMA: 3.02 Buy
50-day EMA: 1.25 Buy
200-day EMA: 0.32 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.83 Buy
20-day SMA: 106.87 Buy
50-day SMA: 105.94 Buy
200-day SMA: 82.62 Buy
8-day EMA: 24.86 Buy
20-day EMA: 10.65 Buy
50-day EMA: 4.39 Buy
200-day EMA: 1.11 Buy

Schwab Emerging Markets Equity ETF Earnings Growth & SCHE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

Schwab Emerging Markets Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):